2.07 USD
-0.11 (-5.05%)
Overall MRM gets a fundamental rating of 2 out of 10. We evaluated MRM against 77 industry peers in the Diversified Consumer Services industry. Both the profitability and financial health of MRM have multiple concerns. MRM is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MRM has reported negative net income.
In the past year MRM has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: MRM reported negative net income in multiple years.
In the past 5 years MRM always reported negative operating cash flow.
1.2 Ratios
MRM has a Return On Assets (1.84%) which is in line with its industry peers.
MRM has a Return On Equity of 15.94%. This is in the better half of the industry: MRM outperforms 75.32% of its industry peers.
MRM has a Return On Invested Capital (0.09%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 15.94% | ||
| ROIC | 0.09% |
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
MRM has a Profit Margin of 1.79%. This is comparable to the rest of the industry: MRM outperforms 53.25% of its industry peers.
In the last couple of years the Profit Margin of MRM has grown nicely.
MRM has a Operating Margin of 0.06%. This is comparable to the rest of the industry: MRM outperforms 46.75% of its industry peers.
In the last couple of years the Operating Margin of MRM has declined.
MRM has a Gross Margin of 27.07%. This is in the lower half of the industry: MRM underperforms 68.83% of its industry peers.
In the last couple of years the Gross Margin of MRM has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.06% | ||
| PM (TTM) | 1.79% | ||
| GM | 27.07% |
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
MRM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MRM has more shares outstanding
MRM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MRM is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.07, we must say that MRM is in the distress zone and has some risk of bankruptcy.
MRM has a Altman-Z score (1.07) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.35 is on the high side and indicates that MRM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.35, MRM is doing worse than 67.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.07 |
ROIC/WACC0.04
WACC2.3%
2.3 Liquidity
A Current Ratio of 0.65 indicates that MRM may have some problems paying its short term obligations.
The Current ratio of MRM (0.65) is worse than 79.22% of its industry peers.
A Quick Ratio of 0.61 indicates that MRM may have some problems paying its short term obligations.
The Quick ratio of MRM (0.61) is worse than 76.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for MRM have decreased strongly by -180.69% in the last year.
MRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.92% yearly.
The Revenue has grown by 21.55% in the past year. This is a very strong growth!
Measured over the past years, MRM shows a quite strong growth in Revenue. The Revenue has been growing by 16.25% on average per year.
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MRM. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
MRM's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.81 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
MRM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:MRM (12/15/2025, 1:25:57 PM)
2.07
-0.11 (-5.05%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners2.08%
Inst Owner Change126.05%
Ins Owners25.57%
Ins Owner ChangeN/A
Market Cap16.36M
Revenue(TTM)8.30B
Net Income(TTM)148.76M
Analysts0
Price TargetN/A
Short Float %4.26%
Short Ratio0.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.31 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.73 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.81 |
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.08
OCFYN/A
SpS6.73
BVpS0.76
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 15.94% | ||
| ROCE | 0.12% | ||
| ROIC | 0.09% | ||
| ROICexc | 0.09% | ||
| ROICexgc | 0.13% | ||
| OM | 0.06% | ||
| PM (TTM) | 1.79% | ||
| GM | 27.07% | ||
| FCFM | N/A |
ROA(3y)1.91%
ROA(5y)-4.19%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-46.9%
ROICexc growth 3YN/A
ROICexc growth 5Y-50.51%
OM growth 3YN/A
OM growth 5Y-50.92%
PM growth 3YN/A
PM growth 5Y32.28%
GM growth 3Y1.14%
GM growth 5Y2.16%
F-Score6
Asset Turnover1.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.35 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.26 | ||
| Cap/Depr | 194.74% | ||
| Cap/Sales | 6.81% | ||
| Interest Coverage | 0.1 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.65 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 1.07 |
F-Score6
WACC2.3%
ROIC/WACC0.04
Cap/Depr(3y)216.74%
Cap/Depr(5y)157.89%
Cap/Sales(3y)7.57%
Cap/Sales(5y)5.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-180.69%
EPS 3YN/A
EPS 5Y47.92%
EPS Q2Q%24.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.55%
Revenue growth 3Y15.33%
Revenue growth 5Y16.25%
Sales Q2Q%34.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y101.04%
EBIT growth 3YN/A
EBIT growth 5Y-42.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.8%
OCF growth 3YN/A
OCF growth 5YN/A
MEDIROM HEALTHCARE TECHNOLOG / MRM FAQ
What is the ChartMill fundamental rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) stock?
ChartMill assigns a fundamental rating of 2 / 10 to MRM.
Can you provide the valuation status for MEDIROM HEALTHCARE TECHNOLOG?
ChartMill assigns a valuation rating of 0 / 10 to MEDIROM HEALTHCARE TECHNOLOG (MRM). This can be considered as Overvalued.
Can you provide the profitability details for MEDIROM HEALTHCARE TECHNOLOG?
MEDIROM HEALTHCARE TECHNOLOG (MRM) has a profitability rating of 3 / 10.
Can you provide the financial health for MRM stock?
The financial health rating of MEDIROM HEALTHCARE TECHNOLOG (MRM) is 0 / 10.